Position in ABEO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,047,979
+$202,667 QoQ
Shares Held
233,924
+45.8% QoQ
Ownership
0.410%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Derivatives in ABEO
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$105,400
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. ABEO ranks #242 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ABEO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,047,979 | 233,924 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $105,400 | 20,000 | Put | Defined | 2026-01-29 | |
| 2025-12-31 | $845,312 | 160,401 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $677,063 | 128,232 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $664,230 | 116,942 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $472,758 | 99,319 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $350,893 | 62,997 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $12,720 | 3,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $75,812 | 10,457 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $4,466 | 1,061 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,453 | 1,105 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $2,978 | 967 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||